Anticancer Profile of a Series of Gold(III) (2‐phenyl)pyridine Complexes

Six phosphorescent (2‐phenyl)pyridine (ppy) gold(III) 2,4,6‐tris(trifluoromethyl)phenyl (FMes) complexes were synthesized and investigated for their anticancer potential. The compounds demonstrated strong antiproliferative activity, with EC₅₀ values in the low micromolar range, along with significant accumulation in HeLa cancer cells after treatment for only 6 h (up to 119 ng gold per milligram of protein as measured by high‐resolution continuum source atomic spectroscopy). Enzyme inhibition studies showed interaction of the gold(III) complexes with thioredoxin reductase (TrxR), a key homeostasis‐regulation flavoprotein. TrxR was inhibited with IC₅₀ values in the micromolar range. Furthermore, five of the complexes displayed selectivity toward TrxR against glutathione reductase (GR, a disulfide reductase structurally related to TrxR) by up to >49‐fold. Because no major differences in bioactivity were observed across the series, (ppy)Au(FMes)(PPh₃)OTf] (complex 4 ) was chosen for further in‐depth biological characterization. Complex 4 was also found to interact with guanosine monophosphate in ¹H NMR studies under long incubation times. Interestingly, 4 induced a significant increase in intracellular levels of reactive oxygen species, which led to late apoptotic events and cytocidal effects.